The front line in the fight against cancer
One of the most powerful tools that an oncologist has in the fight against cancer is access to the newest cancer drugs. New drugs are being developed and tested all the time through a multi-step process called clinical trials. These trials are rigidly controlled and are designed to test the efficacy of new drugs on specific types of cancer.
The Whiteside Institute for Clinical Research is St. Luke’s research department and allows the Regional Cancer Center to conduct clinical trials that would normally only be available at much larger institutions.
If your physician thinks there may be a clinical trial available for you to consider, it will be introduced to you and if you are interested, we will connect you with a member of our research staff to learn more.
Learn more about cancer clinical trials currently being conducted at St. Luke's.
Whiteside Institute for Clinical Research
The Whiteside Institute for Clinical Research is a joint effort between St. Luke's and the University of Minnesota Medical School Duluth to support patient-oriented clinical research in the areas of cancer, lung and heart disease. Support for Whiteside Institute research activities also comes from government agencies and pharmaceutical companies. Whenever appropriate, patients are offered the opportunity to participate in clinical trials and research studies.
Learn more about the Whiteside Institute for Clinical Research.